Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks
Open Access
- 1 March 2018
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 3 (3), 225-233
- https://doi.org/10.1001/jamacardio.2017.5205
Abstract
Observational studies in Western and Asian populations have reported that regular consumption of fish once or twice a week is associated with lower risks of death from coronary heart disease (CHD).1,2 These observations, together with the lower rates of CHD in populations that consumed large amount of foods rich in very-long-chain polyunsaturated fatty acids containing omega-3 fatty acids have prompted interest in assessing whether consumption of marine-derived very-long-chain omega-3 fatty acids (abbreviated “omega-3 FA” in this article) may be protective for CHD.3 These marine-derived omega-3 FAs include eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA) found in fish and other seafood, but not alpha-linolenic acid, which is plant-derived.Keywords
This publication has 31 references indexed in Scilit:
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with DysglycemiaThe New England Journal of Medicine, 2012
- Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarctionEuropean Heart Journal, 2012
- The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular diseaseContemporary Clinical Trials, 2012
- Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?European Heart Journal, 2011
- Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trialBMJ, 2010
- OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial InfarctionCirculation, 2010
- n–3 Fatty Acids and Cardiovascular Events after Myocardial InfarctionThe New England Journal of Medicine, 2010
- Cardiovascular effects of marine omega-3 fatty acidsThe Lancet, 2010
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialThe Lancet, 2008
- Lack of benefit of dietary advice to men with angina: results of a controlled trialEuropean Journal of Clinical Nutrition, 2003